Grant ID | RP110395 |
Awarded On | October 29, 2010 |
Title | A genetic approach to target EWS-FLI1 oncoprotein in Ewing's Sarcoma |
Program | Academic Research |
Award Mechanism | High Impact/High Risk |
Institution/Organization | The University of Texas Southwestern Medical Center |
Principal Investigator/Program Director | James F Amatruda |
Cancer Sites | Bone, Childhood and Adolescent, Sarcoma |
Contracted Amount | $197,565 |
Lay Summary |
Ewing’s sarcoma is a malignant tumor that occurs in children and young adults. Many cases are incurable, and even patients who are cured by combined surgery, chemotherapy and radiation face lifelong medical problems as a result of the treatment. We are seeking new approaches to find treatments that would be more effective and less toxic. Ewing’s sarcoma is caused by the presence of an abnormal protein, called EWS-FLI1, in the tumor cells. No one has figured out how to “shut off” EWS-FLI1 in the cancer cells, or even what in what type of cell in the body Ewing’s Sarcoma actually starts. We will use the zebrafish, a small aquarium fish that has cancer biology very similar to humans, to ta... |